Objective: To determine if racial disparities exist in maternal and fetal cord serum concentrations of bisphenol A (BPA).
Introduction
Bisphenol A (BPA) is a building block of polycarbonate plastic used to manufacture many commonly used items, such as food-storage containers and reusable water bottles. It is also used to make epoxy resins, found in the lining of many food and beverage cans. As a result, BPA is one of the highest volume chemicals produced worldwide and is also a nearly universal contaminant. The 2003 to 2004 National Health and Nutrition Examination Survey data found that BPA was present in the urine of 93% of people tested. 1 Furthermore, an investigation published in January 2011 using the 2003 to 2004 National Health and Nutrition Examination Survey cohort data found detectable levels of BPA in the urine of 96% of pregnant women. 2 BPA binds to plasma membrane and nuclear estrogen receptors. 3 Because it has the potential to exert estrogenic effects, it is considered an endocrine-disrupting chemical. Prenatal exposure to environmentally relevant doses of BPA at critical periods of fetal development has been shown to cause alterations in genital tract development and reproductive function in animals. [4] [5] [6] [7] [8] Animal studies also have shown alterations in behavior associated with low-dose BPA exposure. [9] [10] [11] [12] Although there are no studies showing clear causation of adverse effects in human fetuses, there is a growing concern that humans could be similarly affected. It has been suggested that parental exposure to BPA is associated with shorter anogenital distances in male children. 13 BPA has been shown to cross the human placenta and has been found in amniotic fluid. [14] [15] [16] [17] In 2008, the National Toxicology Program concluded that sufficient scientific evidence exists to justify concern for effects on the brain, behavior and prostate gland in fetuses, infants and children at current human levels of BPA exposure. 18 An excellent review by Ranjit et al. 19 implicated BPA as a potential contributor to intra-uterine growth restriction and low birth weight, outcomes known to be more common in African-Americans. The Endocrine Society and other expert consensus panels have concluded that studies exploring the effects of endocrine-disrupting chemicals, among them BPA, on fetal and infant development in humans are a research priority.
Padmanabhan et al. 22 recently demonstrated measurable levels of BPA in 40 pregnant Michigan women, and several other studies have demonstrated similar concentrations of BPA in pregnant women in Japan, Korea and Germany. 16, 17, 23, 24 However, to our knowledge, our investigation is the first study in the United States to examine matched maternal and fetal-cord serum BPA concentrations. Furthermore, none of these studies have examined whether racial and ethnic differences may exist in maternal or fetal BPA concentrations. This is important as environmental toxin exposure has been implicated as a potential contributor to racial disparities in obstetric outcomes. 19, 25 Therefore, our objective was to determine if racial and ethnic disparities exist in maternal and fetal BPA concentrations, as well as to determine the fetal to maternal ratio for BPA in matched maternal-fetal pairs.
Methods
This was a nested cross-sectional study drawn from a cohort of over 600 healthy, term nulliparous patients treated at the Medical University of South Carolina. All patients lived in the Charleston, SC, USA, area and were without known medical, obstetric or fetal complications. Lack of major structural anomalies was confirmed in all infants at birth. The women were enrolled at routine office visits at term (X37 weeks of gestation), and a maternal blood sample was collected. The women were then followed until delivery, at which time a fetal-cord blood sample was collected. Serum was obtained from each blood sample and stored in cryovials at À80 1C.
In 27 patients (8 African-American, 8 Caucasian and 11 Hispanic) selected at random from among patients in the original cohort of 600 for whom both maternal serum and fetal-cord serum were available, we determined concentrations of BPA in these maternal serum samples and matched fetal-cord blood samples. Maternal data on gestational age at enrollment, height, weight, race, ethnicity and smoking status were collected prospectively by the study coordinator by interview with the patient and from review of the medical record on the day of enrollment. Intrapartum and neonatal data were collected by detailed chart review and from an institutional research quality perinatal database. The study was approved by the Institutional Review Board at the Medical University of South Carolina.
Analysis of BPA was performed as follows: For each sample, 500 ml of serum was pipetted to a 13 Â 100-mm glass tube, followed by 25 ml of the internal standard. The internal standard contained 1 mg ml À1 4-Methylumbelliferyl glucuronide, 1 mg ml
À1
Methylumbelliferyl sulfate, 200 ng ml À1 BPA-d6 (stable isotope internal standard) and 1 mg ml À1 4-Methylumbelliferate (2,3,4-methyl-13C4 stable isotope internal standard). The 4-Methylumbelliferyl glucuronide and sulfate internal standards allow for monitoring the completeness of the glucuronidase/ sulfatase enzymatic hydrolysis necessary to free BPA from these ligands. The stable isotope internal standards were purchased from Cambridge Isotopes (Andover, MA, USA). Following the addition of the internal standards, 25 ml of 1 M acetate buffer, pH 5.5, and 50 ml of glucuronidase/arylsulfatase enzyme solution in 1 M acetate buffer, pH 5.0, was added. The samples were then capped, mixed gently and incubated in a dry heat block for 3 h at 60 1C to enzymatically hydrolyze the BPA from its glucuronide and sulfate forms. Following this incubation, 4 ml dichloromethane was added to each sample tube. Samples were then mixed by mechanical vortexer for 3 min and centrifuged at 2000 g for 10 min. The upper aqueous layer was then removed by vacuum aspiration and the lower organic layer was dried under a stream of nitrogen at 50 1C. The dried residues were then reconstituted with 100 ml of ultrapure water (Nerl Diagnostics LLC, East Providence, RI, USA), mixed by vortexer and transferred to glass autosampler vials for analysis by liquid chromatography-tandem mass spectrometry (LC/MS/MS). All chemicals were purchased from Sigma Diagnostics (St Louis, MO, USA) unless otherwise indicated. All steps of the sample extraction and hydrolysis were performed using glass labware, preventing the possibility of BPA contamination of the samples.
Analyte separation and quantification was carried out on an Agilent (Santa Clara, CA, USA) QQQ LC/MS/MS system equipped with an Agilent APCI source. No constituent parts of the LC/MS/MS used were manufactured from materials known to contain BPA, such as polycarbonate or epoxy. Ensuring that the system is BPAfree is an important consideration, as any background BPA in the instrumentation would lessen the sensitivity of the assay. In addition, water blanks were injected with each run to eliminate the possibility of BPA contamination from the LC/MS/MS hardware (see below). In all, 20 ml of the extract was injected onto an analytical column (Thermo Beta Basic, Walthan, MA, USA, C18, 50 Â 2.1 mm 2 , 5 m). Water and methanol were used in a gradient mobile phase starting at 10% methanol and increased to 85% methanol over 10 min, before being reverted to the initial conditions. A flow rate of 0.8 ml min À1 and column temperature of 50 1C was used throughout. A negative atmospheric pressure chemical ionization mode was used before fragmentation to product ions. A vaporizer temperature of 400 1C was used in the atmospheric pressure chemical ionization source. For BPA, a fragmentor value of 135 V and a collision energy of 15 V were used. Capillary voltage was 4000 V. A multiple-reaction monitoring mode was used to acquire data, and BPA was detected and quantified using an m/z 227-133 precursor product ion transition in the mass spectrometer. Theoretical calibrator values were 0.14, 0.41, 1.23, 3.70, 11.11, 33.33 and 100.00 ng ml À1 . In addition to these calibrators, a blank water sample was subjected to the same extraction and analysis steps as the samples and calibrators. The blank samples were monitored to preclude the possibility of BPA contamination from the extraction labware or the LC/MS/MS instrumentation. No BPA was detected in the blanks in any of the runs. Stable isotope dilution was employed in quantification, with the calibration curve plotted from the relative response of each calibration point (rr ¼ calibrator peak height/BPA-6 internal standard peak height) vs the assigned value in ng ml À1 of the calibrator. A curve point was deemed acceptable if it back-calculated to be within 85 to 115% of the theoretical value when evaluated vs the 1/x 2 weighted curve. Unknown samples were quantified by plotting their relative responses against the calibration curve. The limit of quantification was 0.14 ng ml À1 . Samples with concentrations <0.14 ng ml À1 were reported as 'Below Limit of Quantitation' and treated as undetectable (value of zero).
Statistical analysis was performed using SAS version 9.2 (SAS Institute, Cary, NC, USA) and SPSS 12.0 (SPSS, Inc., Chicago, IL, USA). We compared BPA concentrations among racial and ethnic groups using MannFWhitney U-or Kruskal-Wallis test. Non-parametric correlations between variables were assessed using Spearman's rho. Maternal and neonatal characteristics were compared using the Mann-Whitney U-or Kruskal-Wallis test for non-parametric continuous variables, student's t-test or analysis of variance for normally distributed continuous variables and Fisher's exact test for categorical variables.
Results
Detectable concentrations of BPA were found in 81.5% of maternal and 96.3% of fetal samples. There were no statistically significant differences between racial/ethnic groups with regard to median body mass index, smoking status, infant birth weight, gestational age at maternal blood-sample collection or at delivery, or mean duration between enrollment and delivery (Table 1 ). There were differences between the groups with regard to marital, employment and insurance status (Table 1) . We found that African-Americans had the highest median maternal BPA concentrations, almost 10-fold higher than Caucasians (30.13 vs 3.14 ng ml
À1
; P ¼ 0.038). Hispanic women had intermediate concentrations with a trend towards higher concentrations when compared with Caucasians ( Figure 1 ). In the fetal samples, Hispanics had higher median fetalcord BPA concentrations than non-Hispanics (Figures 2a and b) . When maternal and fetal BPA concentrations were compared, overall median maternal BPA concentrations were 10-fold higher than fetal-cord serum concentrations (14.1 vs 1.3 ng ml À1 ; P ¼ 0.001; Figure 3 ). Matched fetal:maternal ratios of BPA revealed an overall median ratio of 0.03 (range 0 to 4.5), with Hispanics having a higher fetal:maternal ratio than African-Americans or Caucasians (Figure 4 ).
There were no statistically significant non-parametric correlations between either maternal or fetal BPA concentrations and maternal body mass index or infant birthweight (data not shown). There was also no statistically significant correlation between the fetal: maternal ratio of BPA and the duration between enrollment and delivery (data not shown). Maternal obesity status was also dichotomized as body mass index <30 vs X30, and no differences in median BPA concentrations were found ( Figure 5 ). In addition, there were no significant differences in fetal BPA concentrations by fetal gender or in maternal or fetal BPA concentrations by smoking Racial disparity in bisphenol A ER Unal et al status (data not shown). When BPA concentrations (both maternal and fetal), stratified by employment, marital and insurance status, were compared, the only statistically significant difference was higher maternal BPA concentrations in unemployed compared with employed women (Figure 6 ).
Discussion
This study is, to our knowledge, the first investigation to examine maternal-fetal BPA concentrations by racial and ethnic group. The findings of this pilot study suggest the presence of significant racial and ethnic differences in maternal and fetal BPA concentrations, as well as ethnic differences in the fetal:maternal ratio of BPA. These disparities could represent differences in environmental exposure, metabolism or placental transfer, and this determination deserves further investigation. However, the fact that Hispanics had a higher fetal:maternal ratio than Caucasians or African-Americans suggests differences in metabolism or placental transfer rather than simply maternal environmental exposure.
The BPA concentrations in our cohort are higher than those reported in other studies. 16,17,22 -24 However, all studies that also measured fetal-cord blood show consistently higher maternal concentrations compared with fetal-cord concentrations. Lee et al. 24 in Korea found a median maternal concentration of 2.73 ng ml À1 (range non-detectable to 66.46) and a median fetalcord blood concentration of <0.625 ng ml À1 (range non-detectable to 8.86). Schönfelder et al. 23 measured maternal and fetal-cord blood BPA in German mother-infant pairs and found median maternal concentrations of 3.1 ng ml À1 (range 0.3 to 18.9) and median fetal-cord values of 2.3 ng ml À1 (range 0.2 to 9.2). The only investigation measuring serum BPA concentrations in pregnant American women demonstrated a mean maternal serum concentration of 5.9 ng ml À1 (range 0.5 to 22.3). 22 In comparison, our median maternal and fetal concentrations were 14.1 ng ml
À1
(range non-detectable to 153.5) and 1.3 ng ml À1 (range non-detectable to 25.6), respectively. Race/ethnicity was not reported in the Padmanabhan study. 22 Additionally, Schönfelder et al. 23 found higher BPA concentrations in the fetal-cord serum of male compared with female fetuses. Studies in adults have shown higher serum BPA concentrations in men compared with women. In our cohort, there was no statistically significant difference in fetal-cord BPA concentration by fetal gender. Women with polycystic ovary syndrome, a disorder associated with hyperandrogenism, have been shown to have higher serum BPA concentrations than unaffected women, 27 and a positive correlation between both free and total testosterone and serum BPA concentrations has been demonstrated. 26, 27 It is plausible that male fetuses could have higher concentrations than female fetuses, and the lack of a significant difference in our data may be due to the small sample size. These gender differences deserve further study, as BPA has the potential for different effects on fetal reproductive development by gender. A recent abstract found an association between parental BPA exposure and shorter anogenital distances in male children, a finding that clearly warrants further study. 13 If men are truly exposed to higher levels of BPA in utero, they are potentially at increased risk for other adverse outcomes that could be caused by BPA exposure.
The chief weakness of our study is that the maternal and fetal samples were not time-matched. The maternal blood samples were collected X37 weeks of gestation and the fetal-cord blood was collected at delivery. Thus, the two collections were separated by a few days for some patients and a few weeks for others. Although it would have been ideal to have time-matched samples, this weakness does not invalidate our results, as most individuals' BPA exposure is from food, drink and personal care items that are generally similar from day to day.
Because the blood samples were originally collected as part of a study whose chief focus was not BPA analysis, they were obtained using the standard venipuncture techniques and supplies rather than specific procedures to prevent BPA contamination. The lab analysis, however, did take appropriate precautions to rule out contamination from the laboratory equipment (see Methods). The fact that we did have several non-detectable levels of BPA makes contamination during blood collection and storage less likely, but it cannot be completely excluded.
We also did not have information on specific exposures and habits that could have affected the BPA concentrations of the subjects, independent of race and ethnicity. A recent study examining urinary BPA in pregnant women found that cashiers had higher BPA concentrations than other occupations, presumably because of handling of BPA-containing receipt paper. 28 Urinary BPA concentrations have also been positively correlated with consumption of canned foods and drinks. 28, 29 Studies have shown that African-Americans are more likely than Caucasians to use food pantries, which supply many canned products. 30 Additionally, supermarkets primarily in African-American neighborhoods, regardless of income, supply less fresh fruits and vegetables and more canned goods than supermarkets primarily in Caucasian neighborhoods. 31 Prior research has shown a relationship between lower socioeconomic status and higher urinary BPA concentrations. 1, 32 Our racial/ethnic groups were heterogeneous with regard to variables such as insurance and employment status. The African-American and Hispanic women were less likely than Caucasians to have private insurance, and these groups had higher maternal BPA concentrations than Caucasians (though only the Caucasian vs African-American comparison was statistically significant). Additionally, the distribution of non-detectable concentrations in the maternal samples also showed racial/ethnic differences. Of the five maternal non-detectable concentrations, four were in Caucasians and one in an African-American; all Hispanic patients had detectable concentrations of BPA (P ¼ 0.02 for the comparison across the three groups). Reasons for this are not entirely clear, though certainly one can speculate that Caucasians, who in our study cohort were more likely to have private insurance, were of higher socioeconomic status and potentially at lower risk for environmental BPA exposure. Hispanic patients in our cohort were all unemployed and self-pay. Unemployed women in our cohort had significantly higher BPA concentrations than employed women.
It is certainly possible that socioeconomic factors, rather than race or ethnicity itself, are responsible for the differences in maternal BPA concentrations seen in our data. A much larger study would be needed to fully explore these confounders. Socioeconomic differences in BPA exposure, however, do not explain the higher fetal:maternal ratio of BPA seen in Hispanics compared with non-Hispanics. This finding suggests a potential ethnic difference in placental transfer and/or metabolism.
The pharmacokinetics of BPA transfer across the maternal-fetal unit are incompletely understood and are likely complex. One should not be falsely reassured by the fact that fetal concentrations were much lower than maternal concentrations. First, fetal exposure to BPA could differ by gestational age due to changing placental transport and fetal hepatic metabolism, and higher levels earlier in pregnancy would have an increased potential for adverse effects on fetal development. Thus, concentrations at term are not necessarily an accurate measurement of overall fetal BPA exposure, particularly at critical periods early in embryonic and fetal development. Second, cord-serum concentrations do not necessarily reflect tissue levels in other organs. In pregnant mice and monkeys injected with BPA, maternal and fetal-serum concentrations remain relatively low, but up to 10-fold higher concentrations are found in the fetal organs. 33 Relatively low concentrations in cord blood at delivery could belie high concentrations in critical tissues such as brain, liver or kidneys, or gonads at critical developmental junctures. In our patients, there was only one fetal sample with an undetectable BPA concentration compared with five maternal samples. It is difficult to know why this was the case. As acknowledged above, the maternal and fetal samples were not time-matched, which could be the explanation. However, slower placental or fetal metabolism, compared with maternal BPA metabolism and excretion, is another possibility.
It has previously been demonstrated that the unconjugated, biologically active form of BPA rapidly transfers across the human placenta. 15 Several studies have identified BPA in amniotic fluid, and concentrations differ by gestational age. Ikezuki et al. 17 found amniotic-fluid BPA levels at 15 to 18 weeks to be approximately five-fold higher than amniotic-fluid levels at term. Additionally, the 15-to 18-week amniotic-fluid concentrations were also approximately five-fold higher than maternal serum concentrations, suggesting that BPA accumulates in amniotic fluid early in pregnancy. Lower amniotic-fluid concentrations later in pregnancy are likely a result of more mature hepatic conjugation and metabolism of BPA as the fetus develops and matures. Higher levels of fetal exposure earlier in pregnancy, of course, carry a greater potential for adverse developmental outcomes. Future research should focus on serial determinations of BPA concentrations throughout gestation, correlated with obstetric and neonatal outcomes.
In summary, our study is the first investigation to examine maternal and fetal serum BPA concentrations stratified by race and ethnicity. Although our sample size is small, the findings show significantly higher serum BPA concentrations in pregnant AfricanAmerican women compared with Caucasians, significantly higher fetal-cord serum BPA concentrations in Hispanic babies compared with non-Hispanic babies and a higher fetal:maternal ratio of BPA in Hispanic compared with Caucasian and African-American mother-newborn pairs. The greater maternal-fetal exposure of minority groups to BPA could be a potential contributor to racial and ethnic disparities seen in obstetric outcomes. These racial differences in maternal BPA concentrations, and thus fetal exposure, may prove to be due to lifestyle/socioeconomic differences rather than to race or ethnicity itself. If higher BPA concentrations are indeed due to social factors, interventions to reduce behaviors associated with BPA exposure could be effective in reducing the racial disparities currently seen in obstetric outcomes. Although current data linking BPA with adverse fetal effects are mainly limited to animal studies, research into the effects of BPA on human fetal development are ongoing. Whatever the cause, variable maternal and fetal exposure could be associated with endocrine disruption during fetal development. Further study is needed to confirm these results in a larger cohort and to determine if these disparities are the result of differences in environmental exposure, metabolism or placental transfer.
